Announce Date | 04/23/2025 |
EPS Normalized Actual | $2.12 (Miss by $-0.14) |
EPS GAAP Actual | $2.12 (Miss by $-0.14) |
Revenue Actual | $1.53109B |
Revenue Surprise | Beat by $1531.09M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $5.04019 |
EPS GAAP Estimate | $5.04019 |
Revenue Estimate | $2.367935385B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 16.8006 | 26.04 | 16.8006 | 16.8006 | 1 |
Dec 2026 | 17.02441 | 25.7 | 17.02441 | 17.02441 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.93 | 1.93 | 1.53109B | -2.21% | 1531.09M |
FQ4 2024 (Dec 2024) | 2.57 | 2.57 | 1.75396B | 100% | 1753.96M |
FQ3 2024 (Sep 2024) | 4.57 | 4.57 | 2.16004B | 1.54% | 2160.04M |
FQ2 2024 (Jun 2024) | 0 | 0 | 2.13933B | 6.37% | 2139.33M |
FQ1 2024 (Mar 2024) | 0 | 0 | 1.56499B | 0.92% | 1564.99M |
FQ4 2023 (Dec 2023) | 0 | 0 | 0B | NAN% | 0M |
FQ3 2023 (Sep 2023) | 4.04 | 4.04 | 2.12685B | 100% | 2126.85M |
FQ2 2023 (Jun 2023) | 4.13 | 4.13 | 2.00308B | 100% | 2003.08M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
5.04019
Consensus Revenue Estimates
2.367935385B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 2.89 | -- | 2.7952 | 3.00876 | 1 |
FQ3 2027 (Sep 2027) | 5.45 | -- | 5.27123 | 5.67395 | 1 |
FQ2 2027 (Jun 2027) | 6.17 | -- | 5.96762 | 6.42354 | 1 |
FQ1 2027 (Mar 2027) | 2.87 | -- | 2.77586 | 2.98794 | 1 |
FQ4 2026 (Oct 2026) | 5.95695 | -- | 5.95695 | 5.95695 | 0 |
FQ3 2026 (Jul 2026) | 5.52048 | -- | 5.52048 | 5.52048 | 0 |
FQ2 2026 (Jun 2026) | 5.52048 | -- | 5.52048 | 5.52048 | 0 |
FQ1 2026 (Mar 2026) | 0 | -INF | 0 | 0 | 0 |
FQ4 2025 (Oct 2025) | 5.29879 | 51.5 | 5.29879 | 5.29879 | 0 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.94B | -- | 1.89B | 2.01B | 9 |
FQ3 2027 (Sep 2027) | 2.47B | -- | 2.41B | 2.55B | 9 |
FQ2 2027 (Jun 2027) | 2.59B | -- | 2.52B | 2.67B | 9 |
FQ1 2027 (Mar 2027) | 1.88B | -- | 1.84B | 1.94B | 9 |
FQ4 2026 (Oct 2026) | 2.57B | -- | 2.57B | 2.57B | 0 |
FQ3 2026 (Jul 2026) | 2.47B | -- | 2.47B | 2.47B | 0 |
FQ2 2026 (Jun 2026) | 2.47B | -- | 2.47B | 2.47B | 0 |
FQ1 2026 (Mar 2026) | 1.75B | 12.58 | 1.75B | 1.75B | 0 |
FQ4 2025 (Oct 2025) | 2.46B | 28.56 | 2.46B | 2.46B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
0
EPS # of in-lines
3
Revenue # of Beats
7
Revenue # of Misses
0
Revenue # of in-lines
1
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.93 | 1.93 | 100% | |
FQ4 2024 (Dec 2024) | 2.57 | 2.57 | 100% | |
FQ3 2024 (Sep 2024) | 4.57 | 4.57 | 100% | |
FQ2 2024 (Jun 2024) | 0 | 0 | NAN% | |
FQ1 2024 (Mar 2024) | 0 | 0 | NAN% | |
FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
FQ3 2023 (Sep 2023) | 4.04 | 4.04 | 100% | |
FQ2 2023 (Jun 2023) | 4.13 | 4.13 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $1.53B | $1531.09M | 100% |
FQ4 2024 (Dec 2024) | $0B | $1.75B | $1753.96M | 100% |
FQ3 2024 (Sep 2024) | $0B | $2.16B | $2160.04M | 100% |
FQ2 2024 (Jun 2024) | $0B | $2.14B | $2139.33M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.56B | $1564.99M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0B | $0M | NAN% |
FQ3 2023 (Sep 2023) | $0B | $2.13B | $2126.85M | 100% |
FQ2 2023 (Jun 2023) | $0B | $2B | $2003.08M | 100% |